Patent DE3812841A1 successfully refreshed from Google Patents.
US4180064A
Expired / Lapsed
US
⏱️ 0.0 years remaining
System for delivering agent to environment of use over prolonged time
Assignee: Alza Corp
•
Filing: 1976-12-15
•
Granted: 1979-12-25
•
Expires: 1996-12-15
Abstract
Abstract A device for the controlled continuous administration of an active agent to an environment of use is disclosed. The device comprises a body of erodible agent release rate controlling material containing an agent dispersed therethrough; the rate controlling material is a hydrophobic poly(carboxylic acid) having one ionizable carboxylic hydrogen for each 8 to 12 carbon atoms, which material erodes at a controlled and continuous rate over a prolonged period of time in response to the environment by a process of carboxylic hydrogen ionization, thereby releasing the dispersed agent at a controlled rate over a prolonged period of time.
Inventors
- 👤 Jorge Heller
- 👤 Richard W. Baker
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 11:04
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/20; A61K9/2004; A61K9/2022; A61K9/2027; A61K9/0002; A61K9/0004; A61K9/0012; A61K9/0034; A61K9/0039
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
170 words
An intrauterine device for the controlled and continuous local administration of uterine acceptable drug to the uterus consisting essentially of a body sized and shaped as an intrauterine device and formed of drug release rate controlling uterine acceptable material of a hydrophobic poly(acid) represented by the formula: ##STR15## wherein the R's are organic radicals independently selected to provide, on average, from 8 to 22 total carbon atoms for each carboxylic hydrogen, said body of drug release rate controlling material containing a member selected from the group consisting of progestational drugs that have antifertility properties and estrogenic drugs that have antifertility properties dispersed therethrough, said sized and shaped device adapted for insertion and retention prolonged in the uterus, wherein the release rate controlling material erodes at a controlled and continuous rate over a prolonged period of time in response to the environment of the uterus, thereby releasing the dispersed antifertility drug to the uterus at a controlled and continuous rate over a prolonged period of time to produce the desired effect.
Claim 2
Dependent Claim
170 words
An intrauterine device for the controlled and continuous local administration of uterine acceptable drug to the uterus consisting essentially of a body sized and shaped as an intrauterine device and formed of drug release rate controlling uterine acceptable material of a hydrophobic poly(acid) represented by the formula: ##STR15## wherein the R's are organic radicals independently selected to provide, on average, from 8 to 22 total carbon atoms for each carboxylic hydrogen, said body of drug release rate controlling material containing a member selected from the group consisting of progestational drugs that have antifertility properties and estrogenic drugs that have antifertility properties dispersed therethrough, said sized and shaped device adapted for insertion and retention prolonged in the uterus, wherein the release rate controlling material erodes at a controlled and continuous rate over a prolonged period of time in response to the environment of the uterus, thereby releasing the dispersed antifertility drug to the uterus at a controlled and continuous rate over a prolonged period of time to produce the desired effect.
Claim 3
Dependent Claim
130 words
A uterine device for the controlled and continuous local administration of a drug to a uterine environment, said device consisting essentially of a body having means shaped, sized and adapted for insertion and prolonged retention in the uterus, the body formed of a drug release rate controlling material consisting essentially of a hydrophobic poly(carboxylic acid) having from 8 to 22 carbon atoms for each ionizable carboxylic hydrogen, said drug a steroid selected from the group consisting of progestational and estrogenic steroids dispersed within the material, the release rate material eroding when placed in the environment having a pH of 6 to 9 over a prolonged period of time in response to the uterine environment, thereby administering the steroid at a controlled and continuous rate over the prolonged period of time.
Claim 4
Dependent Claim
130 words
A uterine device for the controlled and continuous local administration of a drug to a uterine environment, said device consisting essentially of a body having means shaped, sized and adapted for insertion and prolonged retention in the uterus, the body formed of a drug release rate controlling material consisting essentially of a hydrophobic poly(carboxylic acid) having from 8 to 22 carbon atoms for each ionizable carboxylic hydrogen, said drug a steroid selected from the group consisting of progestational and estrogenic steroids dispersed within the material, the release rate material eroding when placed in the environment having a pH of 6 to 9 over a prolonged period of time in response to the uterine environment, thereby administering the steroid at a controlled and continuous rate over the prolonged period of time.
Claim 5
Dependent Claim
169 words
An intrauterine device for the controlled and continuous administration of a uterine acceptable drug to the uterus consisting essentially of a matrix or hollow body formed of a drug release rate controlling uterine compatible material of a hydrophobic poly(acid) of the formula: ##STR16## wherein the R's are organic radicals independently selected to provide, on average, from 8 to 22 total carbon atoms for each carboxylic hydrogen, said body of drug release rate controlling material containing a member selected from the group consisting of local anesthetics, anti-microbials, and sympathomimetic drug contained in the body, the device shaped, sized and adapted for insertion and prolonged retention in the uterus having a pH in the range of 6 to 9, the release rate controlling material bioeroding when the device is placed in the uterus at a controlled and continuous rate over a prolonged period of time in response to the environment of the uterus, thereby releasing drug to the uterus at a controlled and continuous rate over a prolonged period of time.
Claim 6
Dependent Claim
169 words
An intrauterine device for the controlled and continuous administration of a uterine acceptable drug to the uterus consisting essentially of a matrix or hollow body formed of a drug release rate controlling uterine compatible material of a hydrophobic poly(acid) of the formula: ##STR16## wherein the R's are organic radicals independently selected to provide, on average, from 8 to 22 total carbon atoms for each carboxylic hydrogen, said body of drug release rate controlling material containing a member selected from the group consisting of local anesthetics, anti-microbials, and sympathomimetic drug contained in the body, the device shaped, sized and adapted for insertion and prolonged retention in the uterus having a pH in the range of 6 to 9, the release rate controlling material bioeroding when the device is placed in the uterus at a controlled and continuous rate over a prolonged period of time in response to the environment of the uterus, thereby releasing drug to the uterus at a controlled and continuous rate over a prolonged period of time.
Claim 7
Dependent Claim
115 words
A uterine device for the controlled local administration of a drug to a uterus consisting essentially of a body having means of a shape and size adapted for insertion and prolonged retention in the environment, the body having a wall formed of a drug release rate controlling material consisting essentially of a hydrophobic poly(carboxylic acid) having from 8 to 22 carbon atoms for each ionizable carboxylic hydrogen, a drug dispersed within the material, the release rate material eroding when placed in the uterus having a pH of 6 to 9 over a prolonged period of time in response to the uterine environment, thereby administering drug at a controlled rate over the prolonged period of time.
Claim 8
Dependent Claim
115 words
A uterine device for the controlled local administration of a drug to a uterus consisting essentially of a body having means of a shape and size adapted for insertion and prolonged retention in the environment, the body having a wall formed of a drug release rate controlling material consisting essentially of a hydrophobic poly(carboxylic acid) having from 8 to 22 carbon atoms for each ionizable carboxylic hydrogen, a drug dispersed within the material, the release rate material eroding when placed in the uterus having a pH of 6 to 9 over a prolonged period of time in response to the uterine environment, thereby administering drug at a controlled rate over the prolonged period of time.
References Cited (Backward Citations)
US2066105A
Cited
US2897121A
Cited
US3080346A
Cited
US3081233A
Cited
US3143472A
Cited
GB1124115A
Cited
US3608063A
Cited
US3986510A
Cited
US3811444A
Cited
US3888975A
Cited
US3898986A
Cited
US3971367A
Cited
US3914402A
Cited
US4014987A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1982-12-24 | 1983-06-25 | 1983-12-25 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1986-12-24 | 1987-06-25 | 1987-12-25 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1990-12-24 | 1991-06-25 | 1991-12-25 | $7700.00 | Window Closed / Lapsed |